Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia [3]

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 5, 2002, Pages 758-759

  Betriu, Carmen ^a   Rodríguez Avial, Iciar ^a   Sánchez, Blas Ali ^a   Gómez, María ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Stenotrophomonas maltophila; Tigecycline activity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CEFTAZIDIME; COTRIMOXAZOLE; GLYCYLCYCLINE DERIVATIVE; MINOCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TIGECYCLINE; TIMENTIN; DRUG DERIVATIVE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTEREMIA; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; ENDOCARDITIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; IMMUNE DEFICIENCY; IN VITRO STUDY; LETTER; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SEPTICEMIA; SPAIN; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION; WOUND INFECTION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; STENOTROPHOMONAS MALTOPHILIA; TETRACYCLINES;

EID: 0036850660     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Denton, M. & Kerr, K. G. (1998). Microbiological and clinical aspects of infections associated with Stenotrophomonas maltophilia. Clinical Microbiology Reviews 11, 57-80.
2. Zhang, L., Li, X.-Z. & Poole, K. (2000). Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrobial Agents and Chemotherapy 44, 287-93.
3. Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum P. E. & Testa, R. T. (1999). In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrobial Agents and Chemotherapy 43, 738-44.
4. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
5. National Committee for Clinical Laboratory Standards. (2001). Performance Standards for Antimicrobial Susceptibility Testing: Eleventh Informational Supplement M100-S11. NCCLS, Wayne, PA, USA.
6. Tripodi, M. F., Andreana, A., Sarnataro, G., Ragone, E., Adinolfi, L. E. & Utili, R. (2001). Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia. European Journal of Clinical Microbiology and Infectious Diseases 20, 73-5.
7. Barbier-Frebourg, N., Boutiba-Boubake, I., Nouvello, M. & Lemelan, J. (2000). Molecular investigation of Stenotrophomonas maltophilia isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance. Journal of Hospital Infection 45, 35-41.
8. Muder, R. R., Harris, A. P., Muller, S., Edmond, M., Chow, J. W., Papadakis, K. et al. (1996). Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective multicenter study of 91 episodes. Clinical Infectious Diseases 22, 508-12.